Generic Pharmaceuticals: Patent Expiration and Low Global Utilization Rates Create Opportunities
publication date: Jun 20, 2013
Big Pharma is not dead, but neither are the generics. Let’s take a look at opportunities presented from patent expiry in the US and low generic utilization rates across the globe. We don’t think investors are expecting the “mountain” of opportunities in 2015.
To gain access to the members only content, click here to subscribe. You will be given immediate access to premium content on the site.